Douglas Snyder
Patrimonio netto: 77 522 $ in data 30/06/2026
Patrimonio netto: 77 522 $ in data 30/06/2026
Douglas B. Snyder is currently Chief Legal Officer at IDEAYA Biosciences, Inc. Formerly, Mr. Snyder was Vice-President & Associate General Counsel at GSK Plc from 1999 to 2005, Secretary, Vice President & General Counsel at Eisai, Inc. from 2005 to 2012, Associate General Counsel at US Food & Drug Administration from 1994 to 1999, Secretary, Senior Vice President & General Counsel at Actelion US Holding Co. from 2012 to 2017, and Secretary, Executive VP & Chief Legal Officer at GW Pharmaceuticals Ltd. from 2017 to 2022.
Education includes undergraduate studies at Dickinson College and graduate studies at Columbus School of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 2.080 ( 0% ) | 77 522 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Consigliere Generale | 18/09/2024 |
| Società | Posizione | Fine |
|---|---|---|
| GW PHARMACEUTICALS PLC | Consigliere Generale | 01/01/2022 |
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Consigliere Generale | 01/01/2017 |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Consigliere Generale | 06/05/2012 |
| GSK PLC | Corporate Officer/Principal | 01/01/2005 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01/08/1999 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Actelion US Holding Co.
Actelion US Holding Co. MiscellaneousMiscellaneous Operates as a holding company | Miscellaneous |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in development and commercialization of cannabinoid-based prescription medicines | Commercial Services |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers pharmaceutical products | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Columbus School of Law
Columbus School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale